We are thrilled and humbled to have been invited to the CAP TODAY Roundtables, where we had the opportunity to engage with prominent #industry_leaders and #key_opinion_leaders and share our understanding of the hematology market. Our Chief Strategy Officer, Nitsan Maayan-Rabinowich, and our Chief Commercial Officer, Bob Roopra, shared valuable insights. We invite you to explore their discussions, which include: * A glimpse into our #future_plans * An explanation of our revolutionary #Live_Monolayer_Imaging Technology, which is instrumental in #reducing_the_need_for_additional_smear_reviews, even in cases involving the most clinically severe samples * An overview of our well-established use cases in healthcare settings that cater to patients with #acute_and_severe_clinical_conditions Read more about our contributions to the hematology market in the full article. #BloodDiagnostics #Blood #Oncology #RuralHospitals #UrgentCares #SmallHospitals #Hematology #Laboratory #Horiba #Siemens #Sysmex #CellaVision #Abbott *You can find here a link to the CAP Today page*: https://lnkd.in/dNFdVr9Z
Sight Diagnostics’ Post
More Relevant Posts
-
Coming soon! Join Dr. Zachariah DeFilipp and Dr. Andrew Rogers to review newly released data on existing and emerging therapeutic approaches for chronic #GvHD and their application in academic and community practice settings ➡️ https://bit.ly/3Ozz3SM #MedicalEducation #MedEd #FreeCME #CME #Oncology #Hematology
-
-
Medical Director of Informatics and Digital Pathology at Vanderbilt University Medical Center AI-powered precision pathology, Biomarker discovery, GI pathology
PathAI research presentations at the 2024 #AACR Annual Meeting. Check out our studies which illustrate the advantages of using AI-powered pathology tools for biomarker development. https://lnkd.in/gee2d8v6 #precisiononcoloy #digitalpathology #AIpoweredpathology #PathExplore
PathAI is proud to share seven research presentations, including several with our partners, at the 2024 #AACR Annual Meeting. Our studies illustrate the advantages of using AI-powered pathology tools for biomarker development as part of an overall precision medicine strategy. https://lnkd.in/e7SV9DgS #Oncology #digitalpathology #AIpoweredpathology #machinelearning #PathExplore
-
-
🚀 ASCO 2024 Highlight: Prof Claudio Cerchione, haematologist at the Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori in Meldola, Italy, and one of the authors of the DREAMM7 study, provides a concise summary of the subgroup analyses presented at ASCO 2024, including patients refractory to lenalidomide and those with one or more high-risk cytogenetic abnormalities. For all ASCO 2024 videos, find the link in the comments! #MediMix #ASCO2024 #Hematology #OncologyInnovation
-
Lead Haematology and Flowcytometry, Core Diagnostics. MD PDCC (Haematopathology)
NGS in hematology: The way forward
Upcoming CME update: Dr. Ankita Jaiswal will speak on the topic "Role of NGS panel in Hematology" at the conference Deccan Hemato Link 2024- A Conclave on Advances in Hematology. 📅 Date: 4th Feb 2024 🕐 Time: 12:30-12:45 p.m. 📍Location: Auditorium, Yashoda Hospital, Hyderabad Dr. Ankita Jaiswal Govil #CME #Hematology #Oncology #Conference #COREDiagnostics #WorldCancerDay #CoreCares #COREHyderabad #COREagainstCancer
-
-
📬Article of the Week📜 Suggested by the #BPDCN International Registry❗️-Astghik Voskanyan 📮 North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need ❗️ The North American BPDCN Consortium (#NABC) is a collaborative group of multidisciplinary experts focused on advancing BPDCN care. Their main goals include increasing awareness, defining MRD testing, and exploring non-HSCT treatment approaches. They aim to develop combination therapies, understand BPDCN’s pathobiology, address pediatric cases, and improve quality of life measurements. Additionally, the consortium seeks to create risk stratification tools, expand clinical trial access, and secure funding to support future research and treatment innovations in BPDCN. 📜Authors:Naveen Pemmaraju, MD ,Kendra Sweet ,Jayastu Senapati ,Arthur Frankel , Maria Teresa Garcia Romero , Norma Ruth López Santiago , et al.⬇️ https://lnkd.in/dR_77NT8 #BPDCN, #internationalregistry, #NABC, #oncology, #hematology, #Tagraxofusp
-
-
✨ We spoke with Prof. Dr Richard Cathomas regarding his key takeaways from the ASCO 2024 Annual Meeting! 📽️ You can watch the full video, as well as browse the healthbook ASCO 2024 Newsroom here: https://lnkd.in/en_q3gZj #healthbook #congress #newsroom #ASCO #ASCO2024 #medicalnews #medicine #oncology #hematology
-
-
Unlock the power of #MRD testing in hematologic malignancies! 🩸 Join Dr. Noopur Raje as she delves into its significance for prognosis and treatment in our #CME activity. Stay ahead with the latest insights! Click the link to watch now: https://bit.ly/3UwOGxS #Hematology #CancerCare #HematologyCME #HemOnc #MedEd #HematologyEducation #CancerEducation #OncologyUpdate #MedicalLearning #CMECredits
-
-
🔬 #Research is one of our top priorities! We are proud to announce that we currently have 7 open clinical trials in key areas such as prostate cancer, bladder cancer, benign prostatic hyperplasia (BPH), lithiasis, and robotic surgery—with more than 200 patients enrolled! All of this is possible thanks to our collaboration with HM Hospitales and HM Research Foundation, where we continue to advance medical research. We would like to give special thanks to Francisco Aldea, managing director of #FiHM, as well as to our education and research coordinators, Esther Garcia Rojoía and Kristina Suksova, and principal investigators Javier Romero-Otero, Félix Guerrero Ramos MD PhD FEBU, Javier Feltes Ochoa, Juan Justo Quintas, Ricardo Brime Menéndez, whose efforts are key to our progress. We also want to thank the companies and CROs that support our work: The Janssen Pharmaceutical Companies of Johnson & Johnson, Astellas Pharma, Bayer, @Rocher, Ipsen, Fidia Pharma, Medtronic, Coloplast, Medicina Analítica Consumibles MAC, S.A., Johnson & Johnson, Pfizer, ICON plc 📈 We’ll continue working to improve urological health through research. #InvestigaciónROC #Urology #RoboticSurgery #ClinicalTrials #ROCResearch #clinicaltrial #MedicalResearch
-
-
AstraZeneca's John Longshore, Ph.D., FACMG emphasizes the importance of the Digital PATH Project in harmonizing and standardizing computational pathology tools and supporting its use as an aid to pathologists. #AIOncology #FriendsDx ➡️Learn more about our Digital PATH Project: https://ow.ly/zEfC50QTC7Z ➡️Read the white paper "Supporting the Application of Computational Pathology in Oncology": https://ow.ly/qMzG50QTC7Y
